Ty Francis, PT | |
150 Lincoln Street, Lander, WY 82520-3033 | |
(307) 335-5188 | |
Not Available |
Full Name | Ty Francis |
---|---|
Gender | Male |
Speciality | Physical Therapy |
Experience | 21 Years |
Location | 150 Lincoln Street, Lander, Wyoming |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1538384847 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225100000X | Physical Therapist | 1519 (Alaska) | Secondary |
225100000X | Physical Therapist | PT-1202 (Wyoming) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Wind River Physical Therapy Llc | 4789806167 | 3 |
News Archive
A team of researchers recently demonstrated that mutations in the S protein of SARS-CoV-2 select for amino acid changes that result in a more stable protein than would otherwise be expected.
Theraclone Sciences, Inc., a therapeutic antibody discovery and development company, announced today first dosing of subjects in a Phase 1 clinical trial of TCN-032, a broadly protective, fully human monoclonal antibody for the treatment of influenza A virus.
Researchers at Boston Children's Hospital have found that microscopic particles containing proteins and nucleic acids called exosomes could potentially protect the fragile lungs of premature babies from serious lung diseases and chronic lung injury caused by inflammation.
Benitec Biopharma, a biopharmaceutical company focused on providing potentially curative therapies with its proprietary gene-silencing technology called ddRNAi or "expressed RNAi," is pleased to advise that the fifth patient in the company's 'first in man', Phase I/IIa dose escalation clinical trial of TT-034 for hepatitis C virus (HCV) infection, has today, been dosed at the Duke Clinical Research Unit.
› Verified 2 days ago
Provider Name | Fremont Therapy Group Llc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1477568046 PECOS PAC ID: 5092798488 Enrollment ID: O20040608000562 |
News Archive
A team of researchers recently demonstrated that mutations in the S protein of SARS-CoV-2 select for amino acid changes that result in a more stable protein than would otherwise be expected.
Theraclone Sciences, Inc., a therapeutic antibody discovery and development company, announced today first dosing of subjects in a Phase 1 clinical trial of TCN-032, a broadly protective, fully human monoclonal antibody for the treatment of influenza A virus.
Researchers at Boston Children's Hospital have found that microscopic particles containing proteins and nucleic acids called exosomes could potentially protect the fragile lungs of premature babies from serious lung diseases and chronic lung injury caused by inflammation.
Benitec Biopharma, a biopharmaceutical company focused on providing potentially curative therapies with its proprietary gene-silencing technology called ddRNAi or "expressed RNAi," is pleased to advise that the fifth patient in the company's 'first in man', Phase I/IIa dose escalation clinical trial of TT-034 for hepatitis C virus (HCV) infection, has today, been dosed at the Duke Clinical Research Unit.
› Verified 2 days ago
Provider Name | Wind River Physical Therapy Llc |
---|---|
Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
Provider Identifiers | NPI Number: 1548677701 PECOS PAC ID: 4789806167 Enrollment ID: O20141119002443 |
News Archive
A team of researchers recently demonstrated that mutations in the S protein of SARS-CoV-2 select for amino acid changes that result in a more stable protein than would otherwise be expected.
Theraclone Sciences, Inc., a therapeutic antibody discovery and development company, announced today first dosing of subjects in a Phase 1 clinical trial of TCN-032, a broadly protective, fully human monoclonal antibody for the treatment of influenza A virus.
Researchers at Boston Children's Hospital have found that microscopic particles containing proteins and nucleic acids called exosomes could potentially protect the fragile lungs of premature babies from serious lung diseases and chronic lung injury caused by inflammation.
Benitec Biopharma, a biopharmaceutical company focused on providing potentially curative therapies with its proprietary gene-silencing technology called ddRNAi or "expressed RNAi," is pleased to advise that the fifth patient in the company's 'first in man', Phase I/IIa dose escalation clinical trial of TT-034 for hepatitis C virus (HCV) infection, has today, been dosed at the Duke Clinical Research Unit.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Ty Francis, PT 150 Lincoln St, Lander, WY 82520-2846 Ph: (307) 335-5188 | Ty Francis, PT 150 Lincoln Street, Lander, WY 82520-3033 Ph: (307) 335-5188 |
News Archive
A team of researchers recently demonstrated that mutations in the S protein of SARS-CoV-2 select for amino acid changes that result in a more stable protein than would otherwise be expected.
Theraclone Sciences, Inc., a therapeutic antibody discovery and development company, announced today first dosing of subjects in a Phase 1 clinical trial of TCN-032, a broadly protective, fully human monoclonal antibody for the treatment of influenza A virus.
Researchers at Boston Children's Hospital have found that microscopic particles containing proteins and nucleic acids called exosomes could potentially protect the fragile lungs of premature babies from serious lung diseases and chronic lung injury caused by inflammation.
Benitec Biopharma, a biopharmaceutical company focused on providing potentially curative therapies with its proprietary gene-silencing technology called ddRNAi or "expressed RNAi," is pleased to advise that the fifth patient in the company's 'first in man', Phase I/IIa dose escalation clinical trial of TT-034 for hepatitis C virus (HCV) infection, has today, been dosed at the Duke Clinical Research Unit.
› Verified 2 days ago
Elevate Rehab, Llc Physical Therapist Medicare: Medicare Enrolled Practice Location: 535 E Main St Ste D, Lander, WY 82520 Phone: 307-335-3471 Fax: 307-332-5388 | |
Mrs. Courtney L Hansen, MPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 535 E Main St Ste D, Lander, WY 82520 Phone: 307-335-3471 Fax: 307-332-5388 | |
Mrs. Kim K Asbell, MPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 8168 Highway 789, Lander, WY 82501 Phone: 307-332-5240 Fax: 307-332-5241 | |
Bodyworks Physical Therapy, Pllc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 745 Buena Vista Dr, Lander, WY 82520 Phone: 219-851-5270 | |
Ms. Kathy Lorraine Scott, M.P.T. Physical Therapist Medicare: Medicare Enrolled Practice Location: 150 Lincoln St, Lander, WY 82520 Phone: 307-335-5188 Fax: 307-333-0600 | |
Mr. Lorin Brent Kaufman, MPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 8168 Hwy 789, Lander, WY 82520 Phone: 307-332-5240 Fax: 307-332-5241 | |
Craig Tolman, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 307 Main St, Lander, WY 82520 Phone: 307-332-2715 Fax: 307-332-0314 |